Clik here to view.
Professionals Talk About Panasonic’s 4K Solutions
OSAKA, Japan Panasonic Corporation released a video on November 19, 2014, to introduce examples of 4K solutions that Panasonic is spearheading for AV evolution. In addition to transforming TV...
View ArticleClik here to view.
Phyathai Nawamin International Hospital Thailand Now Offers Spinal Surgery...
BANGKOK Phyathai Nawamin International Hospital’s Spine and Brain Center now offers the newest and updated medical treatment technique for Spinal Surgery with Advanced Technology of Decompression,...
View ArticleClik here to view.
Cell Signaling Technology Wins “Best Antibodies” and “Most Useful Website” at...
WASHINGTON Cell Signaling Technology, a leading provider of antibodies, kits and services, announced today that it has won two Life Science Industry Awards® for “Best Antibodies” and “Most Useful...
View ArticleClik here to view.
ZOLL Files with Japan’s Pharmaceuticals and Medical Devices Agency for New...
CHELMSFORD, Mass. ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that its Japanese subsidiary, Asahi Kasei ZOLL Medical Corp. (AZM), has...
View ArticleClik here to view.
Dr. Reddy’s Announces the Launch of Docetaxel Injection USP
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) announced today that is has launched Docetaxel Injection USP 20 mg/mL and 80 mg/4 mL a therapeutic equivalent generic version of TAXOTERE®...
View ArticleClik here to view.
Right.Brain Foundation e.V. Provides Advanced Navigation System to New...
MUNICH King Norodom Sihamoni and Prime Minister Hun Sen of Cambodia attended the inauguration of the first full-scale public Neurology Center that includes a 90-bed, $10.8 million dollar treatment...
View ArticleClik here to view.
CSTが「最も優れた抗体」および「最も有益なウェブサイト」の部門でライフサイエンス・インダストリー・アワードを受賞
ワシントン （ビジネスワイヤ）– 抗体、キット、サービスを提供する一流企業のセル・シグナリング・テクノロジー（CST）は本日、「最も優れた抗体」（Best Antibodies）および「最も有益なウェブサイト」（Most Useful Website）の2部門でライフサイエンス・インダストリー・アワード（Life Science Industry...
View ArticleClik here to view.
Merck Submits New Drug Application to the Japanese Pharmaceuticals and...
WHITEHOUSE STATION, N.J. Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the company has submitted a new drug application for omarigliptin, its...
View ArticleClik here to view.
专业人士盛赞松下4K解决方案
日本大阪 (美国商业资讯)–松下公司于2014年11月19日发布视频，介绍了松下为推动影音行业发展而引领的4K解决方案的范例。 In addition to transforming TV broadcasts and images of all kinds, 4K is going to touch peoples’ lives with major solutions in a wide...
View ArticleClik here to view.
ResolutionMD® Receives Certification for Web and Mobile Diagnosis in Australia
CALGARY Calgary Scientific Inc., a company known for creating transformative technology for the medical industry and beyond, announced today that ResolutionMD® has received certification from the...
View ArticleClik here to view.
プロフェッショナルが語るパナソニックの4Kソリューション
大阪 （ビジネスワイヤ） — パナソニック株式会社は、2014年11月19日、同社が注力する4Kソリューションの具体例の数々を紹介した動画コンテンツを公開しました。 この動画では、放送や映像の世界はもちろん、私たちの暮らしにより近い、小売店や美術館、セキュリティの分野でのソリューション、さらに建築や医療の分野でのソリューションまで、具体例の数々が紹介されます。 （写真：ビジネスワイヤ）...
View ArticleClik here to view.
AHF Global World AIDS Day Events Focus On Testing and Treatment
PHOTO: For World AIDS Day, AHF will host over 160 events around the world to promote testing, treatment for HIV/AIDS; international commemorations will launch global campaign to connect twenty...
View ArticleClik here to view.
Clik here to view.
AHF在世界艾滋病日开展全球性活动，侧重于检测和治疗
(美国商业资讯) — 图片：在世界艾滋病日，AHF将在全球开展160多场活动，来推动HIV/艾滋病的检测和治疗；国际性的纪念活动将开展全球性运动，在2020年底前使2千万HIV阳性人士获得治疗。有关进一步信息，请访问www.aidshealth.org/wad （点击“世界各地的活动”标签查看国际性活动的列表。）...
View ArticleClik here to view.
Takeda’s Investigational, Oral Proteasome Inhibitor Ixazomib Granted...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy status to the...
View ArticleClik here to view.
武田研究中的用于复发或难治全身性轻链淀粉样变的口服蛋白酶体抑制剂Ixazomib被美国FDA认定为突破性治疗药物
马萨诸塞州坎布里奇和日本大阪 (美国商业资讯) –武田药品工业株式会社(TSE:4502)今天宣布，该公司研究中的用于治疗复发或难治全身性轻链(AL)淀粉样变的口服蛋白酶体抑制剂ixazomib (MLN9708) 被美国食品药品监督管理局(FDA)认定为突破性治疗药物。这是首个被认定为突破性治疗药物的蛋白酶体抑制剂和用于AL淀粉样变的研究药物。...
View ArticleClik here to view.
再発性／難治性の全身性軽鎖アミロイドーシスの治療で、武田薬品の経口治験薬となるプロテアソーム阻害薬ixazomibが米FDAから画期的新薬の指定を受ける
米マサチューセッツ州ケンブリッジ & 大阪 — （ビジネスワイヤ） —...
View ArticleClik here to view.
Elekta Ltd and Medical Intelligence Medizintechnik GmbH defend claims by...
CRAWLEY, United Kingdom Regulatory News: humediQ GmbH has initiated legal proceedings against two companies in the Elekta (STO:EKTAB) (EKTA-B.ST) group. The dispute relates to an agreement from...
View ArticleClik here to view.
Bristol-Myers Squibb Foundation Awards Nine Grants Totaling More than $3.5...
NEW YORK The Bristol-Myers Squibb Foundation today announced nine new grants totaling more than $3.5 million to strengthen efforts in China and India in the fight against hepatitis B virus (HBV) and...
View ArticleClik here to view.
8th Annual OneMedForum San Francisco Expands Its China Forum into Partnering...
NEW YORK OneMedForum announced today that its 8th annual OneMedForum conference, to be held at the San Francisco Marriott Marquis, Jan. 12-13, 2015, will expand its annual China Forum event at the...
View Article